From: Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer
Group
M (%)
U (%)
P
NMIBC
128 (54.9)
105 (45.1)
<0.0001
NBE
0 (0.0)
43 (100.0)